Table 3.
Association between MC1R SNPs and risk of severe HTS.
All subjects (N = 413) | White subjects (N = 327) | |||||
---|---|---|---|---|---|---|
|
|
|||||
MC1R SNP | PRadj1 | 95% CI | P | PRadj2 | 95% CI | P |
V60L | 1.00 | 0.76-1.31 | 0.995 | 1.04 | 0.79-1.38 | 0.778 |
V92M | 1.08 | 0.75-1.55 | 0.681 | 0.78 | 0.47-1.30 | 0.340 |
R151C | 1.29 | 1.01-1.64 | 0.042 | 1.25 | 0.95-1.66 | 0.115 |
R163Q | 1.35 | 1.14-1.53 | <0.001 | 1.46 | 1.20-1.78 | <0.001 |
T314T | 1.12 | 0.84-1.50 | 0.440 | 1.45 | 0.94-2.24 | 0.095 |
Adjusted prevalence-ratio associated with each additional copy of the rare allele, estimated using data from all study subjects, and adjusted for age, sex, burn size, number of operations, and race.
Adjusted prevalence-ratio associated with each additional copy of the rare allele, estimated using data from White subjects only, and adjusted for age, sex, burn size, and number of operations.
Bold indicates statistical significance after accounting for multiple testing in each model (P<0.01).